Results 181 to 190 of about 90,332 (308)

Management of relapsed/refractory AL amyloidosis. [PDF]

Blood Adv
Ling J, Sidiqi MH, Gertz M.
europepmc   +1 more source

Temporal evolution of transthyretin cardiac amyloidosis phenotypes on cardiac magnetic resonance

reservedBackground: Advances in cardiac imaging and disease awareness have led to earlier and more frequent diagnosis of Transthyretin Cardiac Amyloidosis (ATTR-CA).
MONTERSINO, MARTA
core  

Early microglial response to amyloid plaques drives sleep loss in Alzheimer's disease

Alzheimer's &Dementia, Volume 22, Issue 6, June 2026.
Abstract INTRODUCTION Sleep disruption is an early feature of Alzheimer's disease (AD), but the cellular mechanisms linking amyloid pathology to sleep loss remain unclear. METHODS Electroencephalography/electromyography (EEG/EMG) recordings, quantitative EEG analysis, and sleep deprivation were performed in APPswe/PSEN1dE9 (APP/PS1) mice at different ...
Nicholas J. Constantino, Riley E. Irmen, Matthew J. Lanning, Sierra M. Turner, Clair C. Ashley, Caitlin M. Carroll, Evan M. Neary, Dave Rubinow, J. Andy Snipes, Shannon L. Macauley   +9 more
wiley   +1 more source

Hereditary Renal Amyloidosis Associated With a Novel Apolipoprotein A-II Variant

Kidney International Reports, 2017
Tatiana Prokaeva, Harun Akar, Brian Spencer, Andrea Havasi, Haili Cui, Carl J. O’Hara, Olga Gursky, John Leszyk, Martin Steffen, Sabrina Browning, Allison Rosenberg, Lawreen H. Connors   +11 more
doaj   +1 more source

Technetium Pyrophosphate Blood Pool Uptake Mistaken for Myocardial Uptake in Light-Chain Amyloidosis: A Dangerous Misinterpretation. [PDF]

JACC Case Rep
Falk RH.
europepmc   +1 more source

Blood‐based proteomic signature of amyloidosis: identification of novel regulators of amyloid load

Alzheimer's &Dementia, Volume 22, Issue 6, June 2026.
Abstract INTRODUCTION Cerebral amyloidosis is a defining feature of Alzheimer's disease (AD), yet the molecular heterogeneity among amyloidbeta‐positive (Aβ+) individuals remains poorly defined. We aimed to map the proteomic correlates of cerebral amyloidosis and link them to clinical variability within Aβ+ individuals.
Yike Chen, Michael R. Duggan, Jigyasha Timsina, Ying Xu, Daniel Western, Katherine Gong, Menghan Liu, John Budde, Suzanne E. Schindler, John C. Morris, David M. Holtzman, Tammie L. S. Benzinger, Brian A. Gordon, Mahdi Moqri, Knight Alzheimer Disease Research Center (Knight‐ADRC), Laura Ibanez, Keenan A. Walker, Carlos Cruchaga, Muhammad Ali   +18 more
wiley   +1 more source

Remission of refractory lichen amyloidosis with baricitinib. [PDF]

An Bras Dermatol
da Silva TL, Duarte GV.
europepmc   +1 more source

Long‐Term Outcomes of Reduced‐Intensity Conditioning Hematopoietic Stem Cell Transplantation for Patients With Systemic Sclerosis With Impaired Cardiac Function

Arthritis &Rheumatology, Volume 78, Issue 6, Page 1294-1305, June 2026.
Objective High‐intensity conditioning autologous hematopoietic stem cell transplantation (AHSCT) is standard of care for patients with advanced systemic sclerosis (SSc). The role of reduced‐intensity conditioning (RIC) before AHSCT in this population remains unclear.
Yonatan Lean, Carrie Richardson, Anthony J. Esposito, Katy Bedjeti, George E. Georges   +4 more
wiley   +1 more source

Best Practices and Key Barriers for Amyloidosis Patient Care at US Specialized Amyloidosis Centers: An Analysis by ARC-ASPIRE. [PDF]

Clin Med Insights Cardiol
Nativi-Nicolau J, Fajardo J, Galloway A, Khella S, Kumar N, Liedtke M, Lousada I, Patrick T, Moffitt C, Klein L, Tamariz G, Veeraraghavalu K, Haddad-Angulo A.   +12 more
europepmc   +1 more source

Left Atrioventricular Coupling for Predicting Incident Atrial Fibrillation in Cardiac Amyloidosis

openABSTRACT BACKGROUND: Amyloidosis is a heterogeneous group of infiltrative diseases characterized by protein misfolding and extracellular deposition of insoluble amyloid fibrils. When the heart is involved, cardiac amyloidosis (CA) occurs.
LASTEI, SOFIA
core